Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Iulian Pruteanu-Malinici"'
Autor:
Irina Gershgorin, Rakesh Awasthi, Koen van Besien, Lida Bubuteishvili Pacaud, Abhijit Chakraborty, Gilles Salles, Nina D. Wagner-Johnston, Marie José Kersten, Constantine S. Tam, Peter Borchmann, Edmund K. Waller, Özlem Anak, Jufen Chu, Christopher del Corral, Iulian Pruteanu-Malinici, Stephen J. Schuster, Richard T. Maziarz, Samantha Jaglowski, Ulrich Jäger, Edward Waldron, Karen Thudium Mueller, Stephen Ronan Foley
Publikováno v:
Blood advances, 4(3), 560-572. American Society of Hematology
The anti-CD19 chimeric antigen receptor (CAR)–T cell therapy tisagenlecleucel was evaluated in the global, phase 2 JULIET study in adult patients with relapsed/refractory diffuse large B-cell lymphoma (DLBCL). We correlated tisagenlecleucel cellula
Autor:
J Joseph, Melenhorst, Gregory M, Chen, Meng, Wang, David L, Porter, Changya, Chen, McKensie A, Collins, Peng, Gao, Shovik, Bandyopadhyay, Hongxing, Sun, Ziran, Zhao, Stefan, Lundh, Iulian, Pruteanu-Malinici, Christopher L, Nobles, Sayantan, Maji, Noelle V, Frey, Saar I, Gill, Alison W, Loren, Lifeng, Tian, Irina, Kulikovskaya, Minnal, Gupta, David E, Ambrose, Megan M, Davis, Joseph A, Fraietta, Jennifer L, Brogdon, Regina M, Young, Anne, Chew, Bruce L, Levine, Donald L, Siegel, Cécile, Alanio, E John, Wherry, Frederic D, Bushman, Simon F, Lacey, Kai, Tan, Carl H, June
Publikováno v:
Nature. 602(7897)
The adoptive transfer of T lymphocytes reprogrammed to target tumour cells has demonstrated potential for treatment of various cancers
Autor:
Lifeng Tian, Joseph A. Fraietta, Jun Xu, Hans Bitter, Carl H. June, Iulian Pruteanu-Malinici, Edward Pequignot, Alina C. Boesteanu, Roddy S. O’Connor, Changfeng Zhang, Noelle V. Frey, Corin L. Dorfmeier, F. Brad Johnson, Simon F. Lacey, Nicholas Wilcox, Bruce L. Levine, Sadik H. Kassim, Stefan Lundh, Harit Parakandi, E. John Wherry, Megan M. Davis, J. Joseph Melenhorst, Regina M. Young, David L. Porter, Wei-Ting Hwang, Yan Wang, Felipe Bedoya, Alexander C. Huang, David E Ambrose, Li Liu, Mercy Gohil, Jennifer Brogdon, Elena Orlando, Don L. Siegel, Fang Chen, Irina Kulikovskaya, Minnal Gupta
Tolerance to self-antigens prevents the elimination of cancer by the immune system1,2. We used synthetic chimeric antigen receptors (CARs) to overcome immunological tolerance and mediate tumor rejection in patients with chronic lymphocytic leukemia (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eab21abca5e0308fecf5fa6ee68f9d55
https://europepmc.org/articles/PMC6117613/
https://europepmc.org/articles/PMC6117613/
Autor:
Anthony R. Mato, Simon F. Lacey, Vijay Bhoj, Mariusz A. Wasik, Bruce L. Levine, David L. Porter, Stephen J. Schuster, Jennifer Brogdon, Daniel J. Landsburg, J. Joseph Melenhorst, Özlem Anak, Carl H. June, Elise A. Chong, Sunita D. Nasta, Jakub Svoboda, Iulian Pruteanu-Malinici
Patients with diffuse large B-cell lymphoma or follicular lymphoma that is refractory to or that relapses after immunochemotherapy and transplantation have a poor prognosis. High response rates have been reported with the use of T cells modified by c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bff5996afe498892576e3870afb19920
https://europepmc.org/articles/PMC5788566/
https://europepmc.org/articles/PMC5788566/